Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Knight

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Nature Reviews. Rheumatology|May 3, 2024
Rethinking antiphospholipid syndrome to guide future management and researchJason S Knight, Doruk Erkan
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
ReplySrilakshmi Yalavarthi, Jason S Knight
The Journal of Clinical Investigation|November 3, 2025
Neutrophils take center stage in VEXAS syndrome pathogenesisAjay Tambralli, Jason S Knight
Seminars in Immunopathology|February 5, 2022
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndromeJason S Knight, Yogendra Kanthi
Current Opinion in Rheumatology|July 13, 2013
Cardiovascular disease in lupus: insights and updatesJason S Knight, Mariana J Kaplan
Current Opinion in Rheumatology|May 24, 2012
Lupus neutrophils: 'NET' gain in understanding lupus pathogenesisJason S Knight, Mariana J Kaplan
Nature Reviews. Rheumatology|September 30, 2022
Small wonder: nanoparticles feed hydroxychloroquine to activated neutrophilsSomanathapura K NaveenKumar, Jason S Knight
Nature Reviews. Rheumatology|May 16, 2024
Can transcriptomics guide the management of SLE-associated APS?Jason S Knight, Maria G Tektonidou
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2025
Antiphospholipid syndrome: an antibody-mediated disease with emerging therapeutic opportunitiesThalia G Newman, Jason S Knight
Journal of Virology|January 30, 2004
Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activityJason S Knight, Erle S Robertson
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Nature Reviews. Rheumatology|May 3, 2024
Rethinking antiphospholipid syndrome to guide future management and researchJason S Knight, Doruk Erkan
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
ReplySrilakshmi Yalavarthi, Jason S Knight
The Journal of Clinical Investigation|November 3, 2025
Neutrophils take center stage in VEXAS syndrome pathogenesisAjay Tambralli, Jason S Knight
Seminars in Immunopathology|February 5, 2022
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndromeJason S Knight, Yogendra Kanthi
Current Opinion in Rheumatology|July 13, 2013
Cardiovascular disease in lupus: insights and updatesJason S Knight, Mariana J Kaplan
Current Opinion in Rheumatology|May 24, 2012
Lupus neutrophils: 'NET' gain in understanding lupus pathogenesisJason S Knight, Mariana J Kaplan
Nature Reviews. Rheumatology|September 30, 2022
Small wonder: nanoparticles feed hydroxychloroquine to activated neutrophilsSomanathapura K NaveenKumar, Jason S Knight
Nature Reviews. Rheumatology|May 16, 2024
Can transcriptomics guide the management of SLE-associated APS?Jason S Knight, Maria G Tektonidou
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2025
Antiphospholipid syndrome: an antibody-mediated disease with emerging therapeutic opportunitiesThalia G Newman, Jason S Knight
Journal of Virology|January 30, 2004
Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activityJason S Knight, Erle S Robertson
Pageof 17